重組蛋白
重組蛋白質(zhì)是分析生物相互作用的有用工具。在研究實驗室中使用了大量的重組蛋白質(zhì),包括商業(yè)蛋白質(zhì)和在特定研究項目中生成的蛋白質(zhì)。它們在許多應(yīng)用中發(fā)揮著關(guān)鍵作用。
如果您正在尋找具有優(yōu)良質(zhì)量(驗證的生物活性,較低的內(nèi)毒素水平和高純度)的重組蛋白質(zhì)來支持您的研究,您來對地方了。
經(jīng)過16多年的發(fā)展,華美生物已經(jīng)建立了從原核到真核的五大系統(tǒng),用于表達重組蛋白質(zhì)。我們擁有一系列蛋白質(zhì)表達和純化技術(shù),包括基于桿狀病毒外膜蛋白(OMP)的蛋白質(zhì)表達技術(shù),以及膜蛋白表達技術(shù)等。
產(chǎn)品特點
- 超過10,000種重組蛋白覆蓋大多數(shù)基因/靶點;
- 5種表達系統(tǒng),包括大腸桿菌(E.coli)、酵母、桿狀病毒感染的昆蟲細胞、哺乳動物細胞和體外大腸桿菌。而體外大腸桿菌表達系統(tǒng)是華美生物的獨特表達系統(tǒng)。與傳統(tǒng)蛋白表達系統(tǒng)相比,體外大腸桿菌省略了許多過程,如質(zhì)粒轉(zhuǎn)化、細胞培養(yǎng)、收集、破碎和離心等,大大提高了工作效率。
- 多種標(biāo)簽,包括His、GST、Flag、MBP等。
- 廣泛應(yīng)用,包括抗原、細胞分析、結(jié)合分析/蛋白質(zhì)相互作用、細胞培養(yǎng)-無血清培養(yǎng)基、藥物相關(guān)研究、體外酶活性、ELISA標(biāo)準及其原料、體內(nèi)研究、質(zhì)譜標(biāo)準、蛋白芯片、SDS-PAGE控制、蛋白質(zhì)結(jié)構(gòu)分析(晶體/電子顯微鏡)。
- 多種物種,包括人類、小鼠、大鼠、兔子、豚鼠、雞、猴子、豬等。
- 無動物副產(chǎn)品的動物源性重組蛋白質(zhì)。華美生物已開發(fā)出無動物副產(chǎn)品接觸的重組蛋白質(zhì)產(chǎn)品線。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì),或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的抗體,請查看華美生物蛋白質(zhì)定制服務(wù)。
通過選擇目標(biāo)名稱的首字母瀏覽產(chǎn)品。
產(chǎn)品名稱 | 貨號 | 規(guī)格 |
---|---|---|
Recombinant Pongo abelii Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), partial | CSB-YP719225PYX CSB-EP719225PYX CSB-BP719225PYX CSB-MP719225PYX CSB-EP719225PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii NudC domain-containing protein 3 (NUDCD3) | CSB-YP719226PYX CSB-EP719226PYX CSB-BP719226PYX CSB-MP719226PYX CSB-EP719226PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Small muscular protein (SMPX) | CSB-YP719227PYX CSB-EP719227PYX CSB-BP719227PYX CSB-MP719227PYX CSB-EP719227PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Protein POF1B (POF1B), partial | CSB-YP719228PYX CSB-EP719228PYX CSB-BP719228PYX CSB-MP719228PYX CSB-EP719228PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Calcium-binding mitochondrial carrier protein Aralar1 (SLC25A12), partial | CSB-YP719229PYX1 CSB-EP719229PYX1 CSB-BP719229PYX1 CSB-MP719229PYX1 CSB-EP719229PYX1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii UPF0697 protein C8orf40 homolog, partial | CSB-YP719230PYX1 CSB-EP719230PYX1 CSB-BP719230PYX1 CSB-MP719230PYX1 CSB-EP719230PYX1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii NAD-dependent protein deacetylase sirtuin-2 (SIRT2) | CSB-YP719231PYX CSB-EP719231PYX CSB-BP719231PYX CSB-MP719231PYX CSB-EP719231PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (TNFAIP1) | CSB-YP719232PYX CSB-EP719232PYX CSB-BP719232PYX CSB-MP719232PYX CSB-EP719232PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii 3-hydroxyacyl-CoA dehydratase 2 (PTPLB), partial | CSB-YP719233PYX1 CSB-EP719233PYX1 CSB-BP719233PYX1 CSB-MP719233PYX1 CSB-EP719233PYX1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Reticulon-3 (RTN3) | CSB-YP719234PYX CSB-EP719234PYX CSB-BP719234PYX CSB-MP719234PYX CSB-EP719234PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Protein lin-54 homolog (LIN54), partial | CSB-YP719235PYX CSB-EP719235PYX CSB-BP719235PYX CSB-MP719235PYX CSB-EP719235PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Guanine nucleotide-binding protein G (I)/G (S)/G (O) subunit gamma-12 (GNG12) | CSB-YP719236PYX CSB-EP719236PYX CSB-BP719236PYX CSB-MP719236PYX CSB-EP719236PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Cysteine dioxygenase type 1 (CDO1) | CSB-YP719237PYX CSB-EP719237PYX CSB-BP719237PYX CSB-MP719237PYX CSB-EP719237PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Signal recognition particle 19 kDa protein (SRP19) | CSB-YP719238PYX CSB-EP719238PYX CSB-BP719238PYX CSB-MP719238PYX CSB-EP719238PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Acyl-protein thioesterase 1 (LYPLA1) | CSB-YP719239PYX CSB-EP719239PYX CSB-BP719239PYX CSB-MP719239PYX CSB-EP719239PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Rhomboid domain-containing protein 1 (RHBDD1), partial | CSB-YP719240PYX1 CSB-EP719240PYX1 CSB-BP719240PYX1 CSB-MP719240PYX1 CSB-EP719240PYX1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (IDH3B) | CSB-YP719241PYX CSB-EP719241PYX CSB-BP719241PYX CSB-MP719241PYX CSB-EP719241PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Carboxymethylenebutenolidase homolog (CMBL) | CSB-YP719242PYX CSB-EP719242PYX CSB-BP719242PYX CSB-MP719242PYX CSB-EP719242PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Syntaxin-12 (STX12), partial | CSB-YP719243PYX CSB-EP719243PYX CSB-BP719243PYX CSB-MP719243PYX CSB-EP719243PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Potassium voltage-gated channel subfamily V member 1 (KCNV1), partial | CSB-YP719244PYX1 CSB-EP719244PYX1 CSB-BP719244PYX1 CSB-MP719244PYX1 CSB-EP719244PYX1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。
第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條:如何選擇合適的表達載體?
表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。
根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022